Melissa N. McCracken

Person

Mountain View, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
High affinity PD-1 agents and methods of use
- Patent number 11,814,419
- Issue date Nov 14, 2023
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for enhancing immune responsiveness in an individual toward...
- Patent number 10,934,331
- Issue date Mar 2, 2021
- The Board of Trustees of the Leland Stanford Junior University
- Daniel Mark Corey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity PD-1 agents and methods of use
- Patent number 10,800,830
- Issue date Oct 13, 2020
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity PD-1 agents and methods of use
- Patent number 9,562,087
- Issue date Feb 7, 2017
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity PD-1 agents and methods of use
- Patent number 9,546,206
- Issue date Jan 17, 2017
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
- Publication number 20240174729
- Publication date May 30, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
- Publication number 20210230276
- Publication date Jul 29, 2021
- Stephen Willingham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
- Publication number 20210040176
- Publication date Feb 11, 2021
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOGENIC CROSS-PRESENTATI...
- Publication number 20190218260
- Publication date Jul 18, 2019
- The Board of Trustees of the Leland Stanford Junior University
- Daniel Mark Corey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
- Publication number 20170233451
- Publication date Aug 17, 2017
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
- Publication number 20170210803
- Publication date Jul 27, 2017
- The Board of Trustees of the Leland Stanford Junior University
- Stephen Willingham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
- Publication number 20160052990
- Publication date Feb 25, 2016
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE
- Publication number 20160039903
- Publication date Feb 11, 2016
- The Board of Trustees of the Leland Stanford Junior University
- Aaron Michael Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Melissa N. McCracken

Person

Patents Grantslast 30 patents

High affinity PD-1 agents and methods of use

Methods for enhancing immune responsiveness in an individual toward...

High affinity PD-1 agents and methods of use

High affinity PD-1 agents and methods of use

High affinity PD-1 agents and methods of use

Patents Applicationslast 30 patents

HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOGENIC CROSS-PRESENTATI...

HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE

HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE